Research 5287

Latest: November 2026

Once-daily 5% minoxidil foam in postmenopausal women was found to regrow hair regardless of severity, while follicular SULT1A1 testing was reported to predict topical minoxidil response. Cardiovascular events with oral minoxidil were found uncommon with no consistent excess risk, though risk exceeded topical minoxidil and women appeared more susceptible. Current androgenetic alopecia drugs were concluded to work best early and mainly preserve hair, with transplantation the only fix for lost follicles. Red-light and cold-conditioned PRP proved no better than conventional PRP. Hypertrichosis from low-dose oral minoxidil was associated with increased scalp hair density. Topical cetirizine showed no consistent advantage over minoxidil or as an add-on.

Every paper from November →

By year